Personalized, physician-led family cardiac risk assessment with direct access to your cardiology team. Proactive monitoring. Faster interventions. Better outcomes.
Family history of premature cardiovascular disease — defined as a first-degree relative with CVD before age 55 (male) or 65 (female) — is one of the strongest independent risk factors for heart disease. The Framingham Heart Study demonstrated that parental cardiovascular disease increases offspring risk by 50-80%. Yet in standard practice, family history is often reduced to a checkbox on an intake form rather than a launch point for systematic risk evaluation. Beyond general familial risk, specific genetic cardiovascular conditions demand proactive screening. Familial hypercholesterolemia (FH) affects 1 in 250 people (approximately 1.3 million Americans), yet over 90% remain undiagnosed. Hypertrophic cardiomyopathy (HCM), long QT syndrome, Brugada syndrome, arrhythmogenic cardiomyopathy, and hereditary aortopathies (Marfan syndrome, Loeys-Dietz syndrome) are all autosomal dominant conditions where first-degree relatives have a 50% chance of carrying the pathogenic variant. Our concierge family cardiac risk program provides comprehensive pedigree analysis, genetic testing with pre- and post-test counseling, cascade screening of at-risk relatives, advanced imaging for structural and aortopathic conditions, and personalized prevention plans — transforming family history from a passive risk factor into an actionable opportunity for early detection and prevention.
Family cardiac risk assessment requires time, expertise, and coordination that the standard healthcare model simply does not provide. Constructing a detailed three-generation cardiovascular pedigree takes 30-45 minutes alone — time that does not exist in a typical 15-minute visit. Genetic testing for cardiovascular conditions involves complex pre-test counseling about the implications of results (including insurance, psychological impact, and reproductive considerations), careful gene panel selection (a cardiomyopathy panel is very different from a channelopathy panel), and post-test counseling to interpret variants of uncertain significance (VUS) that are found in up to 40% of tested individuals. Cascade screening — systematically testing first-degree relatives of an affected individual — is the most cost-effective strategy for preventing sudden cardiac death in genetic heart disease, yet it requires coordinating care across multiple family members, often in different locations. Concierge care provides 60-minute genetic counseling sessions with cardiogenetics expertise, multi-generational pedigree construction and analysis, coordinated cascade screening with scheduling assistance for family members, and ongoing surveillance protocols tailored to the specific genetic condition identified. For families carrying a pathogenic variant, this program can literally save lives by identifying affected members before their first cardiac event.
Direct physician access, proactive monitoring, and personalized care plans. Concierge cardiology starting at $295/month.